Multiple myeloma. Practical aspects regarding diagnosis and treatment
Journal Title: OncoReview - Year 2011, Vol 1, Issue 1
Abstract
Practical aspects of multiple myeloma diagnosis and treatment has been discussed. Myeloma diagnosis should be supported with immunoglobulin’s isotype and serum free light chain immunoglobulins studies. It is particularly important in non- or oligosecretory mullti (ple myelomas patients. Bone marrow flow cytometry and immunohistochemistry bone marrow studies with monoclonal antibodies against CD38, CD138, CD19, CD-20, CD56 and light chain staining should be performed. Treatment of patients which who are candidates for treatment with high dose therapy with autologous bone marrow transplantation should consist of cyclophosphamide, thalidomide and dexamethasone (CTD) chemotherapy, less commonly treatment with bortezomide/dexamethasone should be considered. Patients not stratified to high dose therapy should receive chemotherapy consists of melphalan, prednisone, thalidomide (MPT) or attenuated (CTDa) chemotherapy. Second line treatment includes bortezomib containing regimens. Most commonly bortezomib/dexamethasone chemotherapy has been used. Primary resistant myelomas patients should receive ESHAP (etoposdide, methyprednisolone, cis-platin, cytosine arabinoside) chemotherapy followed by autologous bone marrow transplantation, or early usage bortezomib containing regimens. High risk myeloma’s patients are treated in United Stated with inductive therapy as patients planned for high dose chemotherapy followed by autologous bone marrow transplantation followed by lenalidomide or lenalidomide/dexamethasone therapy, early bortezomibe containing regfimens induction’s protocols followed by high dose therapy or high dose therapy followed by miniallotransplantation (reduce intensity conditionning allotransplantation).
Authors and Affiliations
Andrzej Pluta
Keywords
Related Articles
- EP ID EP53092
- DOI -
- Views 265
- Downloads 0
Early diagnostics and prevention of anthracycline-induced cardiomyopathy – the role of cardiologist
Anticancer antibiotics, anthracyclines, may cause severe left ventricle systolic dysfunction that is associated with poor clinical prognosis. In this review, we discuss the mechanisms and risk factors of anthracycline-in...
Rola kinaz JAK w patogenezie nowotworów mieloproliferacyjnych Philadelphia-ujemnych. Możliwości terapii celowanej
W ostatnich latach dokonał się istotny postęp w zrozumieniu patogenezy nowotworów mieloproliferacyjnych, w szczególności tych z mutacjami w obrębie genu JAK2. W 2005 roku liczne grupy badawcze potwierdziły występowanie m...
Coronary angioplasty and aortic valve replecement in two patients with multiple myeloma - case reports
Multiple myeloma is a hematological disorder characterized by a clonal proliferation of atypical plasma cells, which produce a monoclonal immunoglobulin. The annual incidence rate in Europe is about 4.5/100 000 persons,...
Mental disorders in cancer patients - clinical approach
Cancer patient is struggling not only with the primary disease, but also is exposed to emotional states that at unfavorable conditions and heavy burden can lead to depression, increased anxiety, and in consequence cause...
Cardio-oncology: What is the future?